60 minutes. Could it be true? Part two /

A look at the human test trials of SU5416, a new angiogenesis inhibitor, which shows promise as a cancer treatment. This is part two of a two-part segment. Ed Bradley reports.

Bibliographic Details
Other Authors:	Bradley, Ed, 1941-2006 (Reporter), Orlando, Lisa Marie (Producer), Radutzky, Michael (Producer)
Format:	Video
Language:	English
Language Notes:	In English.
Published:	New York, NY : Columbia Broadcasting System, 1999.
Subjects:	Cancer > Treatment. Neovascularization inhibitors. United States. Iraq. Oklahoma > Oklahoma City. Internet videos. Television news programs.
Online Access:	Connect to this streaming video (Alexander Street Press)